AC
CRL icon

ASB Consultores’s Charles River Laboratories CRL Stock Holding History

ASB Consultores’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,156
Closed -$313K – 222
2024
Q1 		$313K Buy
+1,156
New +$276K 0.08% 207
2022
Q1 		– Sell
-651
Closed -$245K – 224
2021
Q4 		$245K Buy
+651
New +$253K 0.12% 192

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

ASB Consultores's CRL Position: Q2 2024 in Review

ASB Consultores sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 1,156 shares — an estimated $313K sold.

ASB Consultores first reported a position in CRL in Q4 2021 and held it in 2 quarters. The position peaked at $313K in Q1 2024. 664 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • ASB Consultores reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • ASB Consultores sold 1,156 Charles River Laboratories shares in Q2 2024, an estimated $313K.
  • ASB Consultores first reported a position in Charles River Laboratories in Q4 2021 and held it in 2 quarters.
  • ASB Consultores's Charles River Laboratories position peaked at $313K in Q1 2024.
  • 664 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on ASB Consultores's 13F filing for Q2 2024, filed 12 Aug 2024.